Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver

Oncotarget

Volumn 5, Issue 21, 2014, Pages 10318-10331

  Ella, Ezra ^a   Heim, Denise ^b   Stoyanov, Evgeniy ^a   Harari Steinfeld, Rona ^a   Steinfeld, Israel ^c   Pappo, Orit ^a   Perlman, Temima Schnitzer ^a   Nachmansson, Natalie ^a   Rivkin, Ludmila ^a   Olam, Devorah ^a   Abramovitch, Rinat ^a   Wege, Henning ^b   Galun, Eithan ^a   Goldenberg, Daniel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Chronic hepatitis; Crem; Genomic instability; Hcc; Liver regeneration

Indexed keywords

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CASE REPORT; CELL NUCLEUS; CELL PROLIFERATION; CELL STIMULATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; MOUSE; NONHUMAN; OVERLAPPING GENE; PARTIAL HEPATECTOMY; REGULATOR GENE; TRANSCRIPTOMICS; ANIMAL; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CHROMOSOME 18; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS, CHRONIC; KNOCKOUT MOUSE; LIVER NEOPLASMS; LIVER RESECTION; METABOLISM; POSTOPERATIVE COMPLICATION; TUMOR CELL LINE; UPREGULATION;

CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; E2F1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; P-GLYCOPROTEIN 2; TRANSCRIPTION FACTOR E2F1;

ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; CYCLIC AMP RESPONSE ELEMENT MODULATOR; DISEASE MODELS, ANIMAL; E2F1 TRANSCRIPTION FACTOR; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATECTOMY; HEPATITIS, CHRONIC; HUMANS; LIVER NEOPLASMS; MICE; MICE, KNOCKOUT; P-GLYCOPROTEINS; POSTOPERATIVE COMPLICATIONS; UP-REGULATION;

EID: 84916900265     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2515     Document Type: Article

References (32)

1. Forner A, Llovet JM and Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379(9822):1245-1255.
2. Colotta F, Allavena P, Sica A, Garlanda C and Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009; 30(7):1073-1081.
3. Mauad TH, van Nieuwkerk CM, Dingemans KP, Smit JJ, Schinkel AH, Notenboom RG, van den Bergh Weerman MA, Verkruisen RP, Groen AK, Oude Elferink RPJ, van der Valk MA, Borst P and Offerhaus GJA. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol. 1994; 145(5):1237-1245.
4. Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E and Goldenberg D. Molecular mechanisms of liver carcinogenesis in the Mdr2-knockout mice. Mol Cancer Res. 2007; 5(11):1159-1170.
5. Barash H, Gross ER, Edrei Y, Ella E, Israel A, Cohen I, Corchia N, Ben-Moshe T, Pappo O, Pikarsky E, Goldenberg D, Shiloh Y, Galun E, et al. Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc Natl Acad Sci U S A. 2010; 107(5):2207-2212.
6. Carter SL, Eklund AC, Kohane IS, Harris LN and Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet. 2006; 38(9):1043-1048.
7. Condiotti R, Goldenberg D, Giladi H, Schnitzer-Perlman T, Waddington SN, Buckley SM, Heim D, Cheung W, Themis M, Coutelle C, Simerzin A, Osejindu E, Wege H, et al. Transduction of Fetal Mice With a Feline Lentiviral Vector Induces Liver Tumors Which Exhibit an E2F Activation Signature. Mol Ther. 2013.
8. Gabory A, Jammes H and Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays. 2010; 32(6):473-480.
9. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP and Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 2002; 62(21):6240-6245.
10. Wang SM, Ooi LL and Hui KM. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin Cancer Res. 2011; 17(18):6040-6051.
11. Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, Chung RT, Gould J, Kojima K, Gupta S, Taylor B, Crenshaw A, Gabriel S, et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology. 2013; 144(5):1024-1030.
12. Passon N, Puppin C, Lavarone E, Bregant E, Franzoni A, Hershman J, Fenton M, D'Agostino M, Durante C, Russo D, Filetti S and Damante G. CREM inhibits promoter activity of NIS gene in thyroid cancer cells. Thyroid. 2012.
13. Pigazzi M, Manara E, Baron E and Basso G. ICER expression inhibits leukemia phenotype and controls tumor progression. Leukemia. 2008; 22(12):2217-2225
14. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY and Wang XW. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 2006; 10(2):99-111.
15. Servillo G, Della Fazia MA and Sassone-Corsi P. Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM. Exp Cell Res. 2002; 275(2):143-154.
16. Zmrzljak UP, Korencic A, Kosir R, Golicnik M, Sassone- Corsi P and Rozman D. Inducible cAMP early repressor regulates the Period 1 gene of the hepatic and adrenal clocks. J Biol Chem. 2013; 288(15):10318-10327.
17. Potikha T, Stoyanov E, Pappo O, Frolov A, Mizrahi L, Olam D, Shnitzer-Perlman T, Weiss I, Barashi N, Peled A, Sass G, Tiegs G, Poirier F, et al. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis. Hepatology. 2013; 58(1):192-204.
18. Hanigan MH, Winkler ML and Drinkwater NR. Partial hepatectomy is a promoter of hepatocarcinogenesis in C57BL/6J male mice but not in C3H/HeJ male mice. Carcinogenesis. 1990; 11(4):589-594.
19. Mahler JF, Stokes W, Mann PC, Takaoka M and Maronpot RR. Spontaneous lesions in aging FVB/N mice. Toxicol Pathol. 1996; 24(6):710-716.
20. Iannelli F, Collino A, Sinha S, Radaelli E, Nicoli P, D'Antiga L, Sonzogni A, Faivre J, Annick Buendia M, Sturm E, Thompson RJ, Knisely AS, Natoli G, et al. Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency. Nat Commun. 2014; 5:3850.
21. To MD, Quigley DA, Mao JH, Del Rosario R, Hsu J, Hodgson G, Jacks T and Balmain A. Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer. Mol Cancer Res. 2011; 9(10):1339-1345.
22. Brannan CI, Disteche CM, Park LS, Copeland NG and Jenkins NA. Autosomal telomere exchange results in the rapid amplification and dispersion of Csf2ra genes in wild-derived mice. Mamm Genome. 2001; 12(12):882-886.
23. Jaco I, Canela A, Vera E and Blasco MA. Centromere mitotic recombination in mammalian cells. J Cell Biol. 2008; 181(6):885-892.
24. Burrell RA, McGranahan N, Bartek J and Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013; 501(7467):338-345.
25. Green BM, Finn KJ and Li JJ. Loss of DNA replication control is a potent inducer of gene amplification. Science. 2010; 329(5994):943-946.
26. Huang G and Singh B. Coamplification and cooperation: toward identifying biologically relevant oncogenes. Clin Cancer Res. 2013; 19(20):5549-5551.
27. Xue W, Kitzing T, Roessler S, Zuber J, Krasnitz A, Schultz N, Revill K, Weissmueller S, Rappaport AR, Simon J, Zhang J, Luo W, Hicks J, et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc Natl Acad Sci U S A. 2012; 109(21):8212-8217.
28. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M, Kumada H, Thung SN, Bruix J, Newell P, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011; 140(5):1501-1512 e1502.
29. Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, Colnot S, Godard C, Terris B, Jammes H and Dandolo L. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A. 2008; 105(34):12417-12422.
30. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A and Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2007; 2(9):e845.
31. Acimovic J, Fink M, Pompon D, Bjorkhem I, Hirayama J, Sassone-Corsi P, Golicnik M and Rozman D. CREM modulates the circadian expression of CYP51, HMGCR and cholesterogenesis in the liver. Biochem Biophys Res Commun. 2008; 376(1):206-210.
32. Rauen T, Hedrich CM, Tenbrock K and Tsokos GC. cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med. 2013; 19(4):262-269.